Development of a Drosophila seizure model for in vivo high-throughput drug screening.
about
Alzheimer's disease: the silver tsunami of the 21(st) centuryImage enhancement for tracking the translucent larvae of Drosophila melanogasterA Drosophila systems model of pentylenetetrazole induced locomotor plasticity responsive to antiepileptic drugs.Increased persistent Na+ current contributes to seizure in the slamdance bang-sensitive Drosophila mutant.High-throughput screening and small animal models, where are we?Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery.Regulation of membrane excitability: a convergence on voltage-gated sodium conductance.A new model to study sleep deprivation-induced seizure.Inappropriate Neural Activity during a Sensitive Period in Embryogenesis Results in Persistent Seizure-like Behavior.A knock-in model of human epilepsy in Drosophila reveals a novel cellular mechanism associated with heat-induced seizure.Neural adaptation leads to cognitive ethanol dependence.From bench to drug: human seizure modeling using Drosophilastraightjacket is required for the synaptic stabilization of cacophony, a voltage-gated calcium channel alpha1 subunit.An in vivo large-scale chemical screening platform using Drosophila for anti-cancer drug discovery.Emerging epilepsy models: insights from mice, flies, worms and fish.Status epilepticus: the past and the future.Drosophila melanogaster as a model organism of brain diseasesInvertebrate and fungal model organisms: emerging platforms for drug discovery.Drug Discovery in Fish, Flies, and Worms.A large-scale mutagenesis screen to identify seizure-resistant zebrafish.Treatment with pentylenetetrazole (PTZ) and 4-aminopyridine (4-AP) differently affects survival, locomotor activity, and biochemical markers in Drosophila melanogaster.A Systematic Review on Non-mammalian Models in Epilepsy Research.
P2860
Q26747610-A55D79CD-5087-4D59-A3AE-F4438DD56019Q28476659-2B2A19D8-12EA-41DC-9D91-5EE74BF426C7Q30486566-C650DE51-5956-44BA-AB38-64E0D2FFF43DQ30502114-D7C648A4-74E4-4837-AC4E-7A18B6108008Q33566144-359A86E7-F119-4449-B132-C27B7DADBB60Q34858502-F0636C2E-E91A-4D3F-8A53-B1305D126253Q35024719-6AF81FB8-A603-4780-92BB-C3C50F3317D2Q35478477-7D0780C5-525A-48D8-8171-8FA2D0E72C09Q36297076-74523023-7DB4-4DD2-9F39-0BA41548960FQ36350607-B2E72505-3D66-4FF1-B2FD-62CEB3BBA70EQ36484462-0B01AE6F-8F8A-471C-8794-6679C00F5A89Q36496588-0D4ED58A-9E19-4B5A-871C-D5009925E4CFQ36527225-09821DBC-DF09-4306-8B2D-49400DF6B71DQ36683116-74322BCE-13E4-461F-945A-31A36B52C234Q36757300-344FA204-C833-4211-92F0-8ABC28FB2F69Q37105984-128C31A6-CE32-4135-A823-DA0D44487541Q37139826-52D34062-CA7F-493A-9B39-5A5101420553Q38090660-076D68ED-9B04-4C6E-9C18-46EB78B49A21Q39039978-CC7C0338-CC5B-4845-A588-C31427D91798Q42118042-CFBC1D75-8270-4C2B-B405-9946B8A5443CQ46290034-734BDBA3-1C8F-4847-9372-EC2B49EDC7C9Q55691341-7568ABA2-C019-487E-824B-5451F2181807
P2860
Development of a Drosophila seizure model for in vivo high-throughput drug screening.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Development of a Drosophila seizure model for in vivo high-throughput drug screening.
@en
Development of a Drosophila seizure model for in vivo high-throughput drug screening.
@nl
type
label
Development of a Drosophila seizure model for in vivo high-throughput drug screening.
@en
Development of a Drosophila seizure model for in vivo high-throughput drug screening.
@nl
prefLabel
Development of a Drosophila seizure model for in vivo high-throughput drug screening.
@en
Development of a Drosophila seizure model for in vivo high-throughput drug screening.
@nl
P2093
P2860
P1476
Development of a Drosophila seizure model for in vivo high-throughput drug screening
@en
P2093
Geoff E Stilwell
Scott W Chouinard
Sudipta Saraswati
P2860
P304
P356
10.1111/J.1460-9568.2006.05075.X
P407
P577
2006-10-01T00:00:00Z